LL 255 (Oscimin hyoscyamine sulfate extended release 0.375 mg)
Generic Name: hyoscyamine
Pill imprint LL 255 has been identified as Oscimin hyoscyamine sulfate extended release 0.375 mg.
Oscimin is used in the treatment of irritable bowel syndrome; crohn's disease; anesthesia; urinary incontinence; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Oscimin hyoscyamine sulfate extended release 0.375 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for LL 255 (Oscimin hyoscyamine sulfate extended release 0.375 mg)
- Generic Name:
- hyoscyamine sulfate extended release 0.375 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Larken Laboratories Inc
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
ethylcellulose (10 mPa.s)
D&C Yellow No. 10
FD&C Blue No. 1
More about Oscimin (hyoscyamine)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...